Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Candidiasis/drug therapy"'
Autor:
Parisa Badiee, Teun Boekhout, Pardis Haddadi, Rasoul Mohammadi, Abdolkarim Ghadimi-Moghadam, Jafar Soltani, Ali Zarei Mahmoudabadi, Seyyed Amin Ayatollahi Mousavi, Mohammad Javad Najafzadeh, Kambiz Diba, Ali Reza Salimi-Khorashad, Maneli Amin Shahidi, Fatemeh Ghasemi, Hadis Jafarian
Publikováno v:
Microbiology spectrum, 10(6). American Society for Microbiology
In recent decades, the incidence of Candida infections has increased in immunocompromised patients. This multicenter study aimed to evaluate in vitro antifungal activities of 8 antifungal agents against the Candida species isolated from 10 university
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa050b88342b44d6d768dd022ba3583b
https://pure.knaw.nl/portal/en/publications/1d7ba431-f7ce-469a-b807-cc567400fd83
https://pure.knaw.nl/portal/en/publications/1d7ba431-f7ce-469a-b807-cc567400fd83
Autor:
David Montoir, Isabelle Ourliac-Garnier, Aurélien Planchat, Kossi Efouako Soklou, Carine Picot, Rémi Guillon, Sophie Gazzola, Alain Tonnerre, Cédric Logé, Fabrice Pagniez, Patrice Le Pape
Publikováno v:
European Journal of Medicinal Chemistry
European Journal of Medicinal Chemistry, Elsevier, 2020, 189, pp.112082. ⟨10.1016/j.ejmech.2020.112082⟩
European Journal of Medicinal Chemistry, Elsevier, 2020, 189, pp.112082. ⟨10.1016/j.ejmech.2020.112082⟩
International audience; We identified a new series of azole antifungal agents bearing a pyrrolotriazinone scaffold. These compounds exhibited a broad in vitro antifungal activity against pathogenic Candida spp. (fluconazole-susceptible and fluconazol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c43babd6c0314939c9e45a6a3fd0ca5c
https://hal.archives-ouvertes.fr/hal-03412473
https://hal.archives-ouvertes.fr/hal-03412473
Autor:
Milena Mechkarska, J. Michael Conlon, Laurent Coquet, Thierry Jouenne, Jérôme Leprince, Renoir J. Auguste, Maria Luisa Mangoni
Publikováno v:
Comparative Biochemistry and Physiology-Part D: Genomics and Proteomics
Comparative Biochemistry and Physiology-Part D: Genomics and Proteomics, Elsevier, 2018, 28, pp.72-79. ⟨10.1016/j.cbd.2018.06.006⟩
Comparative Biochemistry and Physiology-Part D: Genomics and Proteomics, Elsevier, 2018, 28, pp.72-79. ⟨10.1016/j.cbd.2018.06.006⟩
International audience; Peptidomic analysis (reversed-phase HPLC combined with MALDI-TOF mass spectrometry and automated Edman degradation) of norepinephrine-stimulated skin secretions from the Trinidadian leaf frog Phyllomedusa trinitatis Mertens 19
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8d8ac132402e20bcd83e05d84ec442a
https://hal-normandie-univ.archives-ouvertes.fr/hal-01973119
https://hal-normandie-univ.archives-ouvertes.fr/hal-01973119
Autor:
Riat, A., Neofytos, D., Coste, A., Harbarth, S., Bizzini, A., Grandbastien, B., Pugin, J., Lamoth, F.
Publikováno v:
Swiss medical weekly, vol. 148, pp. w14622
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1900::df6923607ac9384d1380f625ac1cc737
https://serval.unil.ch/notice/serval:BIB_C56C1C51FBC4
https://serval.unil.ch/notice/serval:BIB_C56C1C51FBC4
Autor:
Estella Glintborg Mathiasen, David S. Perlin, Luis Vale Silva, René Jørgensen, Rasmus Hare Jensen, Kristian Fog Nielsen, Maiken Cavling Arendrup, Ghazalel Doroudian, Dominique Sanglard, K. M. T. Astvad
Publikováno v:
The Journal of antimicrobial chemotherapy
Journal of Antimicrobial Chemotherapy, vol. 70, no. 9, pp. 2551-2555
Journal of Antimicrobial Chemotherapy, vol. 70, no. 9, pp. 2551-2555
Received 2 April 2015; returned 14 April 2015; revised 22 April 2015; accepted 24 April 2015Objectives:The objective of this study was to characterize the underlying molecular mechanisms in consecutiveclinical Candida albicans isolates from a single
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1924cf0c00b8678885d22fb9a19b3fc
Publikováno v:
Clinical Infectious Diseases, vol. 61 Suppl 6, pp. S669-S677
The antifungal "paradoxical effect" has been described as the reversal of growth inhibition at high doses of echinocandins, most usually caspofungin. This microbiological effect appears to be a cellular compensatory response to cell wall damage, resu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::372939bdeede3fffc658402aa4a240b5
http://doc.rero.ch/record/302026/files/civ725.pdf
http://doc.rero.ch/record/302026/files/civ725.pdf
Publikováno v:
Emerging Infectious Diseases. 19(10):1670-3
A new clonal strain of Candida auris is an emerging etiologic agent of fungemia in Delhi, India. In 12 patients in 2 hospitals, it was resistant to fluconazole and genotypically distinct from isolates from South Korea and Japan, as revealed by M13 an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dris___00893::462ad9aabe0d4206f32cd68d674f0e9a
https://hdl.handle.net/20.500.11755/af7fada7-c9fe-4c4f-a448-4764b500aac5
https://hdl.handle.net/20.500.11755/af7fada7-c9fe-4c4f-a448-4764b500aac5
Autor:
Anuradha Chowdhary, Cheshta Sharma, Shalini Duggal, Kshitij Agarwal, Anupam Prakash, Pradeep Kumar Singh, Sarika Jain, Shallu Kathuria, Harbans S. Randhawa, Ferry Hagen, Jacques F. Meis
Publikováno v:
Emerging Infectious Diseases
Emerging Infectious Diseases, 19, 10, pp. 1670-3
Emerging Infectious Diseases, 19(10), 1670-3. Centers for Disease Control and Prevention (CDC)
Emerging Infectious Diseases, 19, 1670-3
Emerging Infectious Diseases, Vol 19, Iss 10, Pp 1670-1673 (2013)
Emerging Infectious Diseases, 19, 10, pp. 1670-3
Emerging Infectious Diseases, 19(10), 1670-3. Centers for Disease Control and Prevention (CDC)
Emerging Infectious Diseases, 19, 1670-3
Emerging Infectious Diseases, Vol 19, Iss 10, Pp 1670-1673 (2013)
A new clonal strain of Candida auris is an emerging etiologic agent of fungemia in Delhi, India. In 12 patients in 2 hospitals, it was resistant to fluconazole and genotypically distinct from isolates from South Korea and Japan, as revealed by M13 an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::aee8e342e7abbfde26dc0fa4c022eab2
http://europepmc.org/articles/PMC3810747
http://europepmc.org/articles/PMC3810747
Publikováno v:
Critical care (London, England), vol. 20, no. 1, pp. 125
Invasive fungal infections, particularly those caused by Candida species, are not uncommon in critically ill patients and are associated with considerable morbidity and mortality. Diagnosis and management of these infections can be challenging. In th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1900::11c0e14e1c9f9c51b9c97257de3719cf
https://serval.unil.ch/resource/serval:BIB_6E6DAB4E22B3.P001/REF.pdf
https://serval.unil.ch/resource/serval:BIB_6E6DAB4E22B3.P001/REF.pdf
Autor:
David S. Perlin, Yanan Zhao, Dimitrios Farmakiotis, Shawn R. Lockhart, Dimitrios P. Kontoyiannis, Jack D. Sobel, Barbara D. Alexander, Winder B. Perez, Dominique Sanglard, Erika Shor, Saad J. Taj-Aldeen, Cristina Jiménez-Ortigosa, Kelley R. Healey
Publikováno v:
Nature Communications, vol. 7, pp. 11128
Nature Communications, Vol 7, Iss 1, Pp 1-10 (2016)
Nature Communications
Nature Communications, Vol 7, Iss 1, Pp 1-10 (2016)
Nature Communications
The fungal pathogen Candida glabrata has emerged as a major health threat since it readily acquires resistance to multiple drug classes, including triazoles and/or echinocandins. Thus far, cellular mechanisms promoting the emergence of resistance to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a40860f10193fc2a5f4ddda277a82fd
https://serval.unil.ch/notice/serval:BIB_55BE139CDF92
https://serval.unil.ch/notice/serval:BIB_55BE139CDF92